心臓マッピング装置の市場規模、シェア、動向分析レポート：タイプ別、適応症別、最終用途別、地域別、セグメント予測、2024年～2030年

心臓マッピング装置市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界の心臓マッピング装置市場規模は、2024年から2030年にかけてCAGR 9.1％を記録し、2030年には36億9,000万米ドルに達すると予測されています。

市場拡大の主な要因としては、不整脈症例と心臓手術患者数の増加、老人人口の増加、心臓マッピングシステムの技術進歩、政府の支援イニシアティブなどが挙げられます。2023年8月に発表されたHeart Rhythm Societyの論文によると、心房細動（AFib）は最も一般的なタイプの心臓不整脈であり、米国の600万人を含む世界中で約4,000万人が罹患しています。

40歳以上の成人の約4人に1人が心房細動を発症する危険性があるが、多くの人はその症状、利用可能な治療法、進行を防ぐための早期介入の重要性を知らないです。心臓マッピングシステムの進歩も市場成長の原動力となります。例えば、2024年6月には、心外膜上の心臓の動脈や静脈を横断してマッピングする多電極バスケットやカテーテルなどの新しいマッピング技術が登場し、真空治療中の3次元的な活性化シーケンスの定義が可能になった。コンピュータによる非接触マッピングでは、心筋内膜に直接触れることなく、数学的アルゴリズムを用いて電位図を再構成し、3次元等電位図を作成します。

心臓電気生理学における遠隔モニタリングと感染予防の進歩は、臨床現場以外でも患者の心拍を継続的にモニタリングすることを可能にし、迅速な治療調整を可能にするとともに、侵襲的手技による感染リスクを軽減します。さらに、主要企業によるいくつかの戦略的取り組みが市場の成長を後押ししています。例えば、ジョンソン・エンド・ジョンソンのバイオセンス・ウェブスターは2024年7月、TrueRef技術を組み込んだマッピングカテーテルOptrellを発売しました。バイオセンス・ウェブスターがカリフォルニア州アーバインで設計したOptrellは、Carto 3システムと一体化した高密度診断カテーテルです。小型電極を固定アレイ状に配置し、複雑な不整脈の正確な電気生理学的マッピングを行う。

心臓マッピング装置市場レポートハイライト

• 接触型心臓マッピングシステム分野は、技術的進歩、主要企業による戦略的イニシアティブ、心臓手術量の増加により、2023年には57.07%超の最大シェアを占めました。
• 心房細動セグメントは、不整脈症例の増加と高齢者人口の増加により、2023年に45.87％超の最大シェアを占めました。
• 病院セグメントは2023年に69.38%の最大シェアを占めました。病院は、高度な心臓マッピング装置などの新技術の採用や評価に重要な役割を果たしています。これらの機器により、病院は心臓不整脈患者に最先端の治療を提供することができ、より良い転帰を確保し、電気生理学分野を発展させることができます。
• 不整脈を含む心血管疾患（CVDs）の患者数の増加により、2023年の世界市場は北米が41.39%のシェアを占めました。製品の上市、規制当局の承認、先進的なヘルスケア・インフラ。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の心臓マッピング装置市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 心臓マッピング装置市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 心臓マッピング装置市場：タイプ推定・動向分析

• 心臓マッピング装置市場：タイプダッシュボード
• 心臓マッピング装置市場：タイプ変動分析
• 心臓マッピング装置市場規模と予測および動向分析、タイプ別、2018～2030年
• 心臓マッピングシステムへのお問い合わせ
• 非接触型心臓マッピングシステム

第5章 心臓マッピング装置市場：適応症の推定・動向分析

• 心臓マッピング装置市場：適応ダッシュボード
• 心臓マッピング装置市場：適応変動分析
• 心臓マッピング装置市場規模と予測および動向分析、適応症別、2018～2030年
• 心房細動
• 心房粗動
• その他

第6章 心臓マッピング装置市場：最終用途の推定・動向分析

• 心臓マッピング装置市場：最終用途ダッシュボード
• 心臓マッピング装置市場：最終用途の変動分析
• 心臓マッピング装置市場規模と予測および動向分析、最終用途別、2018～2030年
• 病院
• 診断センター
• その他

第7章 心臓マッピング装置市場：国、タイプ、最終用途、最終用途別の地域推定・動向分析

• 世界の心臓マッピング装置市場：地域ダッシュボード
• 市場規模と予測動向分析、2018年から2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 主要メーカーによる最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2023
  • Abbott
  • Medtronic
  • BIOTRONIK
  • Acutus Medical
  • APN Health, LLC
  • Johnson &Johnson
  • Biosig Technologies, Inc.
  • Boston Scientific Corporation
  • Kardium, Inc.
  • Koninklijke Philips NV
  • Microport Scientific Corporation

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 Global cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 4 Global cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 5 Global cardiac mapping devices market, by end-use, 2018 - 2030
• Table 6 Global cardiac mapping devices market, by region, 2018 - 2030 (USD Million)
• Table 7 North America cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
• Table 8 North America cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 9 North America cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 10 North America cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 11 U.S. cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 12 U.S. cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 13 U.S. cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 14 Canada cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 15 Canada cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 16 Canada cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 17 Mexico cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 18 Mexico cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 19 Mexico cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Europe cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
• Table 21 Europe cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 22 Europe cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 23 Europe cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 24 UK cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 25 UK cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 26 UK cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 27 Germany cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 28 Germany cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 29 Germany cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 30 France cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 31 France cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 32 France cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 33 Italy cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 34 Italy cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 35 Italy cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Spain cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 37 Spain cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 38 Spain cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 39 Denmark cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 40 Denmark cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 41 Denmark cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 42 Sweden cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 43 Sweden cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 44 Sweden cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 45 Norway cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 46 Norway cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 47 Norway cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific cardiac mapping devices market, by Country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 52 Japan cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 53 Japan cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 54 Japan cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 55 China cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 56 China cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 57 China cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 58 India cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 59 India cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 60 India cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Australia cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
• Table 62 Australia cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 63 Australia cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 64 Australia cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 65 Thailand cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 67 Thailand cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 68 Thailand cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 69 South Korea cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 70 South Korea cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 71 South Korea cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 72 Latin America cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
• Table 73 Latin America cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 74 Latin America cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 75 Latin America cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 76 Brazil cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 77 Brazil cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 78 Brazil cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 79 Argentina cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 80 Argentina cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 81 Argentina cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 82 MEA cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
• Table 83 MEA cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 84 MEA cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 85 MEA cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 86 South Africa cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 87 South Africa cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 88 South Africa cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 90 Saudi Arabia cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 91 Saudi Arabia cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 92 UAE cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 93 UAE cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 94 UAE cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 95 Kuwait cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
• Table 96 Kuwait cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
• Table 97 Kuwait cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
• Table 98 Participant's overview
• Table 99 Financial performance
• Table 100 Key companies undergoing expansions
• Table 101 Key companies undergoing acquisitions
• Table 102 Key companies undergoing collaborations
• Table 103 Key companies launching new types/services
• Table 104 Key companies undergoing partnerships
• Table 105 Key companies undertaking other strategies

List of Figures

• Fig. 1 Cardiac mapping devices market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Cardiac mapping devices market revenues, 2023, (USD Millions)
• Fig. 9 Market driver relevance analysis (Current & future impact)
• Fig. 10 Market restraint relevance analysis (Current & future impact)
• Fig. 11 Porter's five forces analysis
• Fig. 12 PESTLE analysis
• Fig. 13 Cardiac mapping devices market type outlook:
• Fig. 14 Cardiac mapping devices market: type movement analysis
• Fig. 15 Segment dashboard
• Fig. 16 Global contact cardiac mapping systems market, 2018 - 2030 (USD Million)
• Fig. 17 Global non-contact cardiac mapping systems market, 2018 - 2030 (USD Million)
• Fig. 18 Cardiac mapping devices market indication outlook:
• Fig. 19 Cardiac mapping devices market: indication movement analysis
• Fig. 20 Global atrial fibrillation market, 2018 - 2030 (USD Million)
• Fig. 21 Global atrial flutter market, 2018 - 2030 (USD Million)
• Fig. 22 Global others market, 2018 - 2030 (USD Million)
• Fig. 23 Cardiac mapping devices market end-use outlook:
• Fig. 24 Cardiac mapping devices market: end-use movement analysis
• Fig. 25 Global hospitals market, 2018 - 2030 (USD Million)
• Fig. 26 Global diagnostic centers market, 2018 - 2030 (USD Million)
• Fig. 27 Global others market, 2018 - 2030 (USD Million)
• Fig. 28 Regional market place: Key takeaways
• Fig. 29 North America cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 30 U.S. cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 31 Canada cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 32 Mexico cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 33 Europe cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 34 Germany cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 35 UK cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 36 France cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 37 Italy cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 38 Spain cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 39 Asia Pacific cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 40 Japan cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 41 China cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 42 India cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 43 Australia cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 44 Latin America cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 45 Brazil cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 46 MEA cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 47 South Africa cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 48 Saudi Arabia cardiac mapping devices market, 2018 - 2030 (USD Million)
• Fig. 49 Market Participant Categorization
• Fig. 50 Strategy mapping

Cardiac Mapping Devices Market Growth & Trends:

The global cardiac mapping devices market size is expected to reach USD 3.69 billion by 2030, registering a CAGR of 9.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market expansion include the rising arrhythmia cases & number of cardiac surgery patients, growing geriatric population, technological advancements in cardiac mapping systems, and supportive government initiatives. According to the Heart Rhythm Society article published in August 2023, Atrial fibrillation (AFib), the most common type of cardiac arrhythmia, affects nearly 40 million people worldwide, including 6 million in the U.S. Its widespread prevalence underscores the need for advanced diagnostic and treatment options.

Approximately 1 in 4 adults over 40 are at risk of developing AFib, yet many are unaware of its symptoms, available treatments, and the importance of early intervention to prevent progression. Advancements in cardiac mapping systems also drive market growth. For instance, in June 2024, new mapping techniques, such as multielectrode baskets and catheters mapping across cardiac arteries and veins on the epicardium, enabled three-dimensional activation sequence definition during vacuum therapy. Computerized non-contact mapping uses mathematical algorithms to reconstruct electrograms and generate three-dimensional isopotential maps without direct heart endocardium contact.

Advances in remote monitoring and infection prevention in cardiac electrophysiology support continuous patient heart rhythm monitoring outside clinical settings, allowing prompt treatment adjustments and reducing invasive procedure infection risks. Moreover, several strategic initiatives by key players fuel the market's growth. For instance, in July 2024, Johnson & Johnson's Biosense Webster launched the Optrell mapping catheter, incorporating TrueRef technology. Designed in Irvine, California, by Biosense Webster, Optrell is a high-density diagnostic catheter that integrates with the Carto 3 system. It utilizes small electrodes in a fixed array configuration to provide accurate electrophysiological mapping for complex cardiac arrhythmias.

Cardiac Mapping Devices Market Report Highlights:

• The contact cardiac mapping systems segment held the largest share of over 57.07%, in 2023 due to technological advancements, strategic initiatives by key players, and a rising volume of cardiac procedures
• The atrial fibrillation segment held the largest share of over 45.87% in 2023 due to increased cases of arrhythmia and high geriatric population
• The hospitals segment held the largest share of 69.38% in 2023. Hospitals play a vital role in adopting and assessing new technologies, such as advanced cardiac mapping devices. These devices enable hospitals to deliver state-of-the-art care for patients with cardiac arrhythmias, ensuring better outcomes and advancing the field of electrophysiology
• North America dominated the global market with a share of 41.39% in 2023 owing to the increased cases of cardiovascular diseases (CVDs), including arrhythmias. Product launches, regulatory approvals, and advanced healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Indication
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecast timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity price analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Segment
  • 2.2.2. Indication Segment
  • 2.2.3. End-use Segment
  • 2.2.4. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Cardiac Mapping Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing number of cardiac surgery patients
    • 3.2.1.2. Rising arrhythmia cases
    • 3.2.1.3. Technological advancements in mapping systems
    • 3.2.1.4. Growing number of cardiovascular diseases (CVD)
    • 3.2.1.5. Rising geriatric population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of cardiac mapping systems
    • 3.2.2.2. Lack of adequate infrastructure
• 3.3. Cardiac Mapping Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Cardiac Mapping Devices Market: Type Estimates & Trend Analysis

• 4.1. Cardiac Mapping Devices Market: Type Dashboard
• 4.2. Cardiac Mapping Devices Market: Type Movement Analysis
• 4.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Contact cardiac mapping systems
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Non-contact cardiac mapping systems
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Cardiac Mapping Devices Market: Indication Estimates & Trend Analysis

• 5.1. Cardiac Mapping Devices Market: Indication Dashboard
• 5.2. Cardiac Mapping Devices Market: Indication Movement Analysis
• 5.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 5.4. Atrial Fibrillation
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Atrial Flutter
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Cardiac Mapping Devices Market: End Use Estimates & Trend Analysis

• 6.1. Cardiac Mapping Devices Market: End Use Dashboard
• 6.2. Cardiac Mapping Devices Market: End Use Movement Analysis
• 6.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Diagnostic Centers
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Cardiac Mapping Devices Market: Regional Estimates & Trend Analysis by Country, Type, End-use, & End Use

• 7.1. Global Cardiac Mapping Devices Market: Regional Dashboard
• 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Regulatory framework/ reimbursement structure
    • 7.3.4.3. Competitive scenario
    • 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.9. Denmark
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework/reimbursement structure
    • 7.4.9.3. Competitive scenario
    • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.3. South Africa
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. Abbott
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Medtronic
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. BIOTRONIK
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Acutus Medical
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. APN Health, LLC
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Johnson & Johnson
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Biosig Technologies, Inc.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Boston Scientific Corporation
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Kardium, Inc.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Koninklijke Philips N.V
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Microport Scientific Corporation
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives